MASWSHPQFEKGSSHHHHHHSSGSGGGGGENLYFQGTDLLRLRSVRDPHYAPDGTRAVFVEKSIDEEKQYRSHLWIWAADGSVRQWTFGRWRDMKPRFSPRGEIIAFLSDRSGRTQLWLLPANGGEARQLTFFKNGVRDYVWSPDGTFLITLTTLGDDETIEDREEPEKVEVKRADLKPRVVERLYYKSDASGFLDGKRAVLTRIDVLSGKSEALTGREEEIGSFAISPNGRTLAFVANRNEDPDTTFTRDIVLLDLESKAETNLTNGCGTFASLAWSPDGTKLAAIGHDLAYLGATLHRLYVFEPERGTKRVLTADWDVHLGDAMVGDTHADAKGPGPIWASDGSGLYVTASERGRVNLYFVSLAGPIVPVIEGNFHLYGLAIHPSEQQAIAAISSPTSVGDLYAVSLADGTKTRLTRANEALENEVVFADAEPFTYRSADGLEIQGWIMKPPELDEGEKAPLVVEIHGGPHAMYGFTFFHELQLLASSGYAVLFTNPRGSHGYGQSFVNAVRGDYGGMDYEDIMAGVDAAISKFDFIDKERLGVTGGSYGGFMTNWIVGHTDRFKAAVTQRSISNWLSFSGVSDIGYFFTKWEVGCDVWEDAERLWHHSPLKYVKHMRTPLLILHSERDYRCPIEQAEQLFVALKQLGRETKLVRFPDANHDLSRTGNPALRLERLRHIVDWFDRYLKG
The protein construct used for SAXS contains and additional N-terminal MASWSHPQFEKGSSHHHHHHSSGSGGGGGENLYFQGT amino acid extension and two point mutations (I277L, V491A) relative to the native sequence in UniProt.